Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen - Takeaways - MDSpire

Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen

Share

1

Mike Doustdar is the new CEO of Novo Nordisk, focusing on regaining market share in the competitive obesity market.
2

Bob Nelsen, co-founder of ARCH Venture Partners, discusses the impact of AI in biotech and China's rise in biomedical innovation.
3

The conversation took place at the J.P. Morgan Healthcare Conference in San Francisco, highlighting key industry insights.
4

Novo Nordisk aims to shift its cautious R&D culture to enhance drug development and innovation.
5

Listeners can access the podcast episode on platforms like Apple Podcasts and Spotify for further insights.